155 related articles for article (PubMed ID: 10716762)
1. Clenbuterol reduces degeneration of exercised or aged dystrophic (mdx) muscle.
Zeman RJ; Peng H; Danon MJ; Etlinger JD
Muscle Nerve; 2000 Apr; 23(4):521-8. PubMed ID: 10716762
[TBL] [Abstract][Full Text] [Related]
2. Power output of fast and slow skeletal muscles of mdx (dystrophic) and control mice after clenbuterol treatment.
Lynch GS; Hinkle RT; Faulkner JA
Exp Physiol; 2000 May; 85(3):295-9. PubMed ID: 10825417
[TBL] [Abstract][Full Text] [Related]
3. Long-term clenbuterol administration alters the isometric contractile properties of skeletal muscle from normal and dystrophin-deficient mdx mice.
Hayes A; Williams DA
Clin Exp Pharmacol Physiol; 1994 Oct; 21(10):757-65. PubMed ID: 7867226
[TBL] [Abstract][Full Text] [Related]
4. Clenbuterol, a beta 2-agonist, retards wasting and loss of contractility in irradiated dystrophic mdx muscle.
Zeman RJ; Zhang Y; Etlinger JD
Am J Physiol; 1994 Sep; 267(3 Pt 1):C865-8. PubMed ID: 7943213
[TBL] [Abstract][Full Text] [Related]
5. Recovery of damaged skeletal muscle in mdx mice through low-intensity endurance exercise.
Frinchi M; Macaluso F; Licciardi A; Perciavalle V; Coco M; Belluardo N; Morici G; Mudò G
Int J Sports Med; 2014 Jan; 35(1):19-27. PubMed ID: 23868681
[TBL] [Abstract][Full Text] [Related]
6. Force and power output of diaphragm muscle strips from mdx and control mice after clenbuterol treatment.
Lynch GS; Hinkle RT; Faulkner JA
Neuromuscul Disord; 2001 Mar; 11(2):192-6. PubMed ID: 11257477
[TBL] [Abstract][Full Text] [Related]
7. Low dose formoterol administration improves muscle function in dystrophic mdx mice without increasing fatigue.
Harcourt LJ; Schertzer JD; Ryall JG; Lynch GS
Neuromuscul Disord; 2007 Jan; 17(1):47-55. PubMed ID: 17134898
[TBL] [Abstract][Full Text] [Related]
8. Effects of beta 2-agonist administration and exercise on contractile activation of skeletal muscle fibers.
Lynch GS; Hayes A; Campbell SP; Williams DA
J Appl Physiol (1985); 1996 Oct; 81(4):1610-8. PubMed ID: 8904577
[TBL] [Abstract][Full Text] [Related]
9. Exercise and clenbuterol as strategies to decrease the progression of muscular dystrophy in mdx mice.
Dupont-Versteegden EE
J Appl Physiol (1985); 1996 Mar; 80(3):734-41. PubMed ID: 8964730
[TBL] [Abstract][Full Text] [Related]
10. Effects of aging and voluntary exercise on the function of dystrophic muscle from mdx mice.
Wineinger MA; Abresch RT; Walsh SA; Carter GT
Am J Phys Med Rehabil; 1998; 77(1):20-7. PubMed ID: 9482375
[TBL] [Abstract][Full Text] [Related]
11. Use of Evans blue dye to compare limb muscles in exercised young and old mdx mice.
Wooddell CI; Zhang G; Griffin JB; Hegge JO; Huss T; Wolff JA
Muscle Nerve; 2010 Apr; 41(4):487-99. PubMed ID: 19813196
[TBL] [Abstract][Full Text] [Related]
12. Contractile properties of clenbuterol-treated mdx muscle are enhanced by low-intensity swimming.
Hayes A; Williams DA
J Appl Physiol (1985); 1997 Feb; 82(2):435-9. PubMed ID: 9049721
[TBL] [Abstract][Full Text] [Related]
13. Contractile function and low-intensity exercise effects of old dystrophic (mdx) mice.
Hayes A; Williams DA
Am J Physiol; 1998 Apr; 274(4):C1138-44. PubMed ID: 9575811
[TBL] [Abstract][Full Text] [Related]
14. Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points.
Capogrosso RF; Mantuano P; Cozzoli A; Sanarica F; Massari AM; Conte E; Fonzino A; Giustino A; Rolland JF; Quaranta A; De Bellis M; Camerino GM; Grange RW; De Luca A
J Appl Physiol (1985); 2017 Apr; 122(4):828-843. PubMed ID: 28057817
[TBL] [Abstract][Full Text] [Related]
15. Beneficial versus adverse effects of long-term use of clenbuterol in mdx mice.
Dupont-Versteegden EE; Katz MS; McCarter RJ
Muscle Nerve; 1995 Dec; 18(12):1447-59. PubMed ID: 7477069
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effects of voluntary wheel running on the properties of dystrophic mouse muscle.
Hayes A; Williams DA
J Appl Physiol (1985); 1996 Feb; 80(2):670-9. PubMed ID: 8929614
[TBL] [Abstract][Full Text] [Related]
17. Selective activation of α7 nicotinic acetylcholine receptor (nAChRα7) inhibits muscular degeneration in mdx dystrophic mice.
Leite PE; Gandía L; de Pascual R; Nanclares C; Colmena I; Santos WC; Lagrota-Candido J; Quirico-Santos T
Brain Res; 2014 Jul; 1573():27-36. PubMed ID: 24833065
[TBL] [Abstract][Full Text] [Related]
18. Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1.
De Luca A; Pierno S; Liantonio A; Cetrone M; Camerino C; Fraysse B; Mirabella M; Servidei S; Rüegg UT; Conte Camerino D
J Pharmacol Exp Ther; 2003 Jan; 304(1):453-63. PubMed ID: 12490622
[TBL] [Abstract][Full Text] [Related]
19. Multiple pathological events in exercised dystrophic mdx mice are targeted by pentoxifylline: outcome of a large array of in vivo and ex vivo tests.
Burdi R; Rolland JF; Fraysse B; Litvinova K; Cozzoli A; Giannuzzi V; Liantonio A; Camerino GM; Sblendorio V; Capogrosso RF; Palmieri B; Andreetta F; Confalonieri P; De Benedictis L; Montagnani M; De Luca A
J Appl Physiol (1985); 2009 Apr; 106(4):1311-24. PubMed ID: 19131478
[TBL] [Abstract][Full Text] [Related]
20. Examining potential drug therapies for muscular dystrophy utilising the dy/dy mouse: I. Clenbuterol.
Hayes A; Williams DA
J Neurol Sci; 1998 May; 157(2):122-8. PubMed ID: 9619633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
